This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Susanne Kindermann, PhD
Regulatory Group Director at F. Hoffmann-La Roche AG
Speaker

Profile

Susanne Kindermann is a Regulatory Group Director in CMC Regulatory Affairs at Roche, Switzerland. She has 18 years of diverse industry experience spanning start-up environments, CMOs, and large pharmaceutical companies.
Holding a PhD in Chemistry, Susanne currently leads the global cmc regulatory strategy for Roche's New Modalities portfolio, including oligonucleotides, peptides, and synthetic molecules. Her work is dedicated to translating innovative drug development into successful global Health Authority approvals. She is a member of the European Pharma Oligonucleotide Consortium (EPOC).

Agenda Sessions

  • Industry Comments on EMA Oligo Guideline

    08:35